This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinates of Health
Disparities: Social Determinates of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinates of Health
Clinical Trials
From the Editor
Search Clinical Trials
Trials in Progress
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Oral EPI-7386
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2023
EAU 2023
SES AUA 2023
All Conferences
View All
PCF
UroToday Home
Video Lectures
ASCO GU 2022
ASCO GU 2022 VL
Search
Clear
Most recent
Most hits
Most likes
Most dislikes
Title alphabetical
Recently modified
Recently viewed
Author alphabetical
Random
10
20
30
40
50
Highlights In Urothelial Carcinoma at GU ASCO 2022 - Guru Sonpavde
Details
Guru Sonpavde joins Ashish Kamat to highlight key presentations showing promising data for new therapies in urothelial carcinoma from the ASCO GU 2022 annual meeting. Among the studies, he highlights the TROPHY-U-01 trial, the CheckMate 901 trial, the LEAP-011 study of first-line pembrolizumab with or without lenvatinib in patients with advanced urothelial carcinoma, the DS8201-A-U105 trial of tra...
Sacituzumab Govitecan in Combination With Pembrolizumab in Metastatic Urothelial Cancer – Petros Grivas
Details
Alicia Morgans and Petros Grivas discuss the TROPHY-U-01 data looking at patients who had progression of metastatic disease after exposure to platinum-based chemotherapy and who are now receiving sacituzumab govitecan in combination with a PDL-1 approach. Dr. Grivas gives a background on the combination of sacituzumab govitecan in combination with PD1 approaches. They also discuss the logistics of...
Next-Generation Sequencing - Discussing Results With Patients - Bishoy Faltas
Details
Alicia Morgans and Bishoy Faltas discuss the use of Next-Generation Sequencing (NGS) and how to use it in practice and communicate results to patients. Dr. Faltas gives a deep background on how NGS works and how it can be used to improve patient care. They also discuss why clinicians need to get familiar with the nuances of this sequencing to maximize the benefit of NGS. Because there are multiple...
Anticipated Data from Transformative Trials at ASCO GU 2022 - Oliver Sartor
Details
Alicia Morgans and Oliver Sartor discuss the upcoming American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium on Feb 17-20, 2022, and the data from key presentations in prostate cancer, bladder cancer, and kidney cancer. Biographies: A. Oliver Sartor, MD, Professor of Medicine and Medical Director, Tulane Cancer Center; C. E. and Bernadine Laborde Professor of Cancer Resear...
Start
Prev
1
2
3
4
5
6
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free